(Q41649179)

6 October 2017

title

Allogeneic tumor-specific cytotoxic T lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1371720

19 September 2022

author name string

J. M. Redd

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1371720

19 September 2022

A. C. Lagarde

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1371720

19 September 2022

C. A. Kruse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1371720

19 September 2022

D. Bellgrau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1371720

19 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1371720

19 September 2022

publication date

1 January 1992

1 reference

Cancer Immunology, Immunotherapy

6 October 2017

published in

1 reference

6 October 2017

volume

34

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

349-354

1 reference

Imbalances in T cell subpopulations in human gliomas

6 October 2017

cites work

1 reference

12 December 2020

The expression of a tissue-specific self-peptide is required for allo-recognition.

1 reference

12 December 2020

Immunotherapy for recurrent malignant glioma: an interim report on survival

1 reference

12 December 2020

The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens

1 reference

12 December 2020

Interleukin-2-activated lymphocytes from brain tumor patients. A comparison of two preparations generated in vitro

1 reference

12 December 2020

SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo

1 reference

12 December 2020

T cells mediate transplantation tolerance

1 reference

12 December 2020

Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implications for generation of an autoimmune T-cell repertoire

1 reference

12 December 2020

In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas

1 reference

12 December 2020

Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors

1 reference

12 December 2020

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

12 December 2020

Interleukin-2 and lymphokine activated killer (LAK) cells in the treatment of malignant glioma: clinical and experimental studies

1 reference

12 December 2020

T cells can distinguish between allogeneic major histocompatibility complex products on different cell types

1 reference

12 December 2020

Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

1 reference

12 December 2020

T cells can be cytotoxic without making interleukin 2: a model of separate pathways of induction

1 reference

12 December 2020

Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Immunogenetic control of brain tumor growth in rats

1 reference

12 December 2020

Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take

1 reference

12 December 2020

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

1 reference

12 December 2020

Immunogenetic and immunologic aspects of gliosarcoma growth in rats

1 reference

12 December 2020

Cytotoxic T lymphocyte responses to spontaneous tumors: immunogenicity dependent on the recognition of processed tumor antigens

1 reference

12 December 2020

The fate of parental strain small lymphocytes in F1 hybrid rats

1 reference

12 December 2020

Natural Killer Cells Do Not Belong to the Recirculating Lymphocyte Population

1 reference

12 December 2020

Induction of cytotoxic T cell precursors in vivo. Role of T helper cells

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Immunology of transplantation in the central nervous system

1 reference

12 December 2020

Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes

1 reference

12 December 2020

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2.

1 reference

12 December 2020

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

12 December 2020

The immunological response of Wistar rats to the intracranially implanted C-6 glioma cell line.

1 reference

12 December 2020

In vivo separation of two classes of T cells as determined by negative selection after the injection of UV-treated allogeneic lymphoid cells

1 reference

12 December 2020

Different rules govern help for cytotoxic T cells and B cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741557

1 reference

Dimensions Publication ID

6 October 2017

1049598231

0 references

1 reference